Literature DB >> 22807294

Modeling the effect of forward scatter and aberrations on visual acuity after endothelial keratoplasty.

Jay W McLaren1, Sanjay V Patel.   

Abstract

PURPOSE: To evaluate the effects on visual acuity of forward scatter and aberrations typical of those after Descemet stripping endothelial keratoplasty (DSEK).
METHODS: Twenty normal eyes of 20 subjects (ages 22-57 years) were examined with best spectacle correction. Under photopic conditions, high-contrast visual acuities (HCVAs) were measured by using ETDRS charts. Visual acuity was also measured by using aberrated charts that simulated the typical high-order aberrations at 12 months after DSEK. Forward scatter was induced by viewing the eye charts through a 1-mm-thick layer of scattering solution (Amco Clear, at a concentration of 4000 nephelometric turbidity units) and was measured with a straylight meter.
RESULTS: Forward scatter increased from 1.19 ± 0.11 log straylight parameter (log[s]; mean ± SD) without induced scatter to 1.57 ± 0.06 log(s) with induced scatter (P < 0.001). Induced scatter reduced HCVA on the nonaberrated chart by 2.7 Snellen letters, from 20/19 (Snellen equivalent) to 20/21 (P < 0.001) and by 2.1 letters on the aberrated chart, from 20/25 to 20/28 (P = 0.005). Addition of aberrations reduced HCVA by more than twice the number of Snellen letters than did induced scatter, by 6.4 letters with low scatter (P < 0.001), and by 5.8 letters with high scatter (P < 0.001).
CONCLUSIONS: Under typical clinical testing conditions, increased forward scatter has minimal effect on visual acuity. High-order aberrations are a more likely cause of degraded visual acuity than is forward scatter in eyes with clear corneas after DSEK.

Entities:  

Mesh:

Year:  2012        PMID: 22807294     DOI: 10.1167/iovs.12-10011

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Corneal Optical Changes Associated with Induced Edema in Fuchs Endothelial Corneal Dystrophy.

Authors:  Katrin Wacker; Jay W McLaren; Katrina M Kane; Sanjay V Patel
Journal:  Cornea       Date:  2018-03       Impact factor: 2.651

2.  Corneal Higher-Order Aberrations in Descemet Membrane Endothelial Keratoplasty versus Ultrathin DSAEK in the Descemet Endothelial Thickness Comparison Trial: A Randomized Clinical Trial.

Authors:  Matthew J Duggan; Jennifer Rose-Nussbaumer; Charles C Lin; Ariana Austin; Paula C Labadzinzki; Winston D Chamberlain
Journal:  Ophthalmology       Date:  2019-02-16       Impact factor: 12.079

Review 3.  In vivo confocal microscopy of the ocular surface: from bench to bedside.

Authors:  Edoardo Villani; Christophe Baudouin; Nathan Efron; Pedram Hamrah; Takashi Kojima; Sanjay V Patel; Stephen C Pflugfelder; Andrey Zhivov; Murat Dogru
Journal:  Curr Eye Res       Date:  2013-11-11       Impact factor: 2.424

4.  Post-DSAEK optical changes: a comprehensive prospective analysis on the role of ocular wavefront aberrations, haze, and corneal thickness.

Authors:  Holly B Hindman; Krystel R Huxlin; Seth M Pantanelli; Christine L Callan; Ramkumar Sabesan; Steven S T Ching; Brooke E Miller; Tim Martin; Geunyoung Yoon
Journal:  Cornea       Date:  2013-12       Impact factor: 2.651

5.  Effect of Donor Graft Thickness on Clinical Outcomes after Descemet Stripping Automated Endothelial Keratoplasty.

Authors:  Sepehr Feizi; Mohammad Ali Javadi
Journal:  J Ophthalmic Vis Res       Date:  2019 Jan-Mar

6.  Simulation of visual acuity by personalizable neuro-physiological model of the human eye.

Authors:  Csilla Fülep; Illés Kovács; Kinga Kránitz; Gábor Erdei
Journal:  Sci Rep       Date:  2019-05-24       Impact factor: 4.379

7.  Early Changes in Visual Quality and Corneal Structure after DMEK: Does DMEK Approach Optical Quality of a Healthy Cornea?

Authors:  Maria Satue; Miriam Idoipe; Alicia Gavin; Maria Romero-Sanz; Vasilios S Liarakos; Antonio Mateo; Elena Garcia-Martin; Alejandro Blasco-Martinez; Antonio Sanchez-Perez
Journal:  J Ophthalmol       Date:  2018-09-23       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.